Envista Holdings Corporation (NVST) Stock
Envista stock price chart
NVST stock quote & key statistics
Envista annual financials
Income statement →| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2025 | $2.72B | $47.0M | $1.20 |
| FY2024 | $2.51B | -$1.12B | $0.73 |
| FY2023 | $2.57B | -$100.2M | $1.53 |
| FY2022 | $2.57B | $243.1M | $1.94 |
| FY2021 | $2.51B | $340.5M | $1.98 |
Fiscal year ending December 31. Source: company filings via EODHD.
About Envista Holdings Corporation
Envista Holdings Corporation, along with its subsidiaries, is actively involved in the development, sale, and global marketing of dental products, serving markets in the United States, China, and worldwide. Organized into two primary segments, Specialty Products & Technologies and Equipment & Consumables, the company delivers a comprehensive array of dental solutions to meet the diverse needs of oral surgeons, prosthodontists, periodontists, and orthodontists.
Under its Specialty Products & Technologies segment, Envista offers an extensive portfolio that includes dental implant systems, guided surgery systems, biomaterials, and both prefabricated and custom-built prosthetics. Recognizable brands within this segment include Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, and Orascoptic, providing essential tools and technologies for advanced dental procedures. Additionally, the segment features orthodontic products like brackets, wires, clear aligners, and digital orthodontic treatments under brands such as Damon, Insignia, AOA, and Spark, alongside software solutions for treatment planning and clinical imaging management.
Envista's Equipment & Consumables segment focuses on providing dental professionals with essential equipment, including digital imaging systems, sensors, and software for enhanced visualization and magnification. The segment also offers endodontic systems, restorative materials, rotary burs, impression materials, bonding agents, cements, and infection prevention products under trusted brands like Dexis, Gendex, i-CAT, Kerr, Metrex, Pentron, and Sybron Endo. These products are crucial for maintaining high standards of care in dental offices, clinics, and hospitals worldwide.
Founded in 2018 and headquartered in Brea, California, Envista Holdings Corporation continues to expand its market presence and innovation in dental healthcare through strategic acquisitions, partnerships, and advancements in technology. The company's commitment to providing comprehensive dental solutions underscores its mission to enhance patient care and improve outcomes across the dental industry.
Envista stock FAQ
What is the Envista stock ticker symbol?
Envista Holdings Corporation trades on the NYSE under the ticker symbol NVST.
What sector and industry is Envista in?
Envista Holdings Corporation is classified in the Healthcare sector, Medical Instruments & Supplies industry.
How many employees does Envista have?
Envista Holdings Corporation has about 12,000 full-time employees.
What were Envista's revenue and earnings last fiscal year?
Envista reported revenue of $2.72B and net income of $47.0M in fiscal 2025, with earnings per share of $1.20. Revenue grew 8.3% from the prior year.
Is Envista in the S&P MidCap 400?
Yes. Envista Holdings Corporation (NVST) is a component of the S&P MidCap 400, the benchmark index of U.S. mid-cap stocks.
Is Envista in the Russell 1000?
Yes. Envista Holdings Corporation (NVST) is a component of the Russell 1000, which tracks roughly the 1,000 largest U.S. companies.
When did Envista go public?
Envista stock began trading on September 18, 2019.
S&P MidCap 400 Healthcare stocks
All S&P MidCap 400 →- ARWRArrowhead Pharmaceuticals
- ATRAptarGroup
- AVTRAvantor
- BMRNBioMarin Pharmaceutical
- BTSGBrightSpring Health Services
- CORTCorcept Therapeutics
- CYTKCytokinetics
- EHCEncompass Health
- ELANElanco Animal Health
- ENSGEnsign
- EXELExelixis
- GMEDGlobus Medical
- HALOHalozyme Therapeutics
- JAZZJazz Pharmaceuticals
- KRYSKrystal Biotech
- MEDPMedpace
- MOHMolina Healthcare
- NBIXNeurocrine Biosciences
- PENPenumbra
- RGENRepligen
- ROIVRoivant Sciences
- THCTenet Healthcare
- UTHRUnited Therapeutics
- XRAYDENTSPLY SIRONA